ArrayExpress Uploaderarrayexpress_sidhumanHuman cancer cell line, PC310uMHuman cancer cell line, PC310uMHuman cancer cell line, PC3.5uMHuman cancer cell line, PC3.5uMHuman cancer cell line, PC3vehicleHuman cancer cell line, PC3vehicleHuman cancer cell line, LNCAP10uMHuman cancer cell line, LNCAP10uMHuman cancer cell line, LNCAP.5uMHuman cancer cell line, LNCAP.5uMHuman cancer cell line, LNCAPvehicleHuman cancer cell line, LNCAPvehicleHuman cancer cell line, VCAP10uMHuman cancer cell line, VCAP10uMHuman cancer cell line, VCAP.5uMHuman cancer cell line, VCAP.5uMHuman cancer cell line, VCAPvehicleHuman cancer cell line, VCAPvehicleHuman cancer cell line, NCIH66010uMHuman cancer cell line, NCIH66010uMHuman cancer cell line, NCIH660.5uMHuman cancer cell line, NCIH660.5uMHuman cancer cell line, NCIH660vehicleHuman cancer cell line, NCIH660vehicle208004We analyzed transcriptional changes in 4 prostate cancer cell lines following treatment with the BET inhibitor I-BET762 using Affymetrix...24293458E-GEOD-56352/profile/8773/arrayexpressuploader224cancercellgenomeprostateprostate cancerDec.12, 2014Falseinhibition-of-bet-bromodomain-proteins-as-a-therapE-GEOD-56352_A-AFFY-44Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancerJul.11, 2014We analyzed transcriptional changes in 4 prostate cancer cell lines following treatment with the BET inhibitor I-BET762 using Affymetrix Human Genome U133 Plus 2.0 Arrays. Four prostate cancer cell lines (NCI-H660, VCaP, LNCaP, PC-3) were treated with DMSO (control) or I-BET762 at 0.5uM or 10uM concentrations for 24 hours. Two biological replicates are included for each treatment group.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-56352http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-56352/samples/